Houston Weight Loss Center - Katy

Houston Weight Loss Center in Katy, Texas has operated as a medical weight loss practice since 1996, focusing exclusively on physician-supervised programs that combine GLP-1 receptor agonist peptides with structured nutritional protocols. The clinic's longevity in the Houston metropolitan area reflects its established approach to treating obesity and metabolic dysfunction through evidence-based pharmacotherapy rather than surgical intervention. Located in Katy, the practice serves patients throughout Fort Bend and Harris counties who seek alternatives to bariatric surgery or who have struggled with conventional diet-and-exercise programs that failed to produce sustained results.

The clinic's medical weight loss protocols center on two FDA-approved GLP-1 peptides: liraglutide and semaglutide. Liraglutide, administered as a daily subcutaneous injection, works by mimicking the incretin hormone GLP-1 to slow gastric emptying and reduce appetite signals in the hypothalamus. Semaglutide, available in weekly injection form, provides similar appetite suppression mechanisms with extended duration of action. Both peptides have demonstrated efficacy in clinical trials for producing 10-15% body weight reduction when combined with caloric restriction. The Houston Weight Loss Center's protocols include initial dosage titration over 4-8 weeks to minimize gastrointestinal side effects, ongoing monitoring of hemoglobin A1c and lipid panels, and adjustment of peptide dosing based on individual response and tolerance. Patients receive specific meal planning guidance designed to complement the appetite-suppressing effects of GLP-1 therapy, with emphasis on protein intake to preserve lean muscle mass during weight reduction.

The clinic's medical team includes nurse practitioners who conduct initial consultations, establish weight loss goals, and perform ongoing monitoring throughout treatment. These consultations involve comprehensive metabolic assessment, review of previous weight loss attempts, evaluation of contraindications to GLP-1 therapy such as personal or family history of medullary thyroid carcinoma, and discussion of realistic timelines for achieving target weight. The nurse practitioners develop individualized treatment plans that specify peptide selection, dosing schedules, nutritional targets, and follow-up intervals. This provider model allows for accessible medical supervision while maintaining clinical oversight of peptide prescribing and metabolic monitoring.

Patients at Houston Weight Loss Center typically begin with an in-person consultation at the Katy location to establish baseline measurements, review medical history, and receive instruction on peptide self-administration technique. Subsequent visits may occur in-person or via telehealth, depending on patient preference and clinical needs, with most protocols requiring monthly check-ins during active weight loss phases. The hybrid consultation model accommodates working professionals and parents who face scheduling constraints while ensuring adequate medical supervision of peptide therapy. Patients receive detailed meal planning resources, access to the clinic for questions between scheduled visits, and guidance on managing common GLP-1 side effects such as nausea or constipation. The practice emphasizes that peptide therapy represents one component of comprehensive weight management, requiring concurrent attention to dietary patterns, physical activity, sleep quality, and behavioral factors that influence long-term weight maintenance.

Houston Weight Loss Center's 28-year presence in the Katy medical community and 4.8-star rating across 257 Google reviews indicates consistent patient satisfaction with its focused approach to medical weight loss. The clinic's specialization in GLP-1 peptides rather than offering a broad menu of aesthetic or wellness services allows for concentrated expertise in appetite regulation pharmacotherapy and the specific challenges of managing patients on liraglutide or semaglutide. For Katy-area residents seeking medical supervision of peptide-based weight loss without the complexity of multi-specialty wellness centers, this established practice provides a straightforward pathway to accessing FDA-approved GLP-1 therapy with structured nutritional support and ongoing metabolic monitoring.